COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension

Completed · Phase 3

Conditions studied: Hypertension

In brief

This study was designed to determine whether treatment with COREG MR is more effective at maintaining a better lipid profile than treatment with TOPROL-XL for hypertension.

Key facts

Study ID

NCT00273052

Run by

GlaxoSmithKline

People needed

514

Starts

2006-01-05

Expected to finish

2007-12-28

Last updated by the study team

2018-06-25

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented history of hypertension
• Triglycerides of 120-400 mg/mL
• LDLc levels not requiring lipid lowering medication.

You may not qualify if…

• Has known contraindication to alpha- or beta-blocker therapy.
• Has taken any non-ocular beta-blockers within three months before screening.
• Has Type I or II diabetes.
• Taking lipid lowering medications.

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Montgomery, Alabama, United States
• GSK Investigational Site — Chandler, Arizona, United States
• GSK Investigational Site — Mesa, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Fayetteville, Arkansas, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Carmichael, California, United States
• GSK Investigational Site — Healdsburg, California, United States
• GSK Investigational Site — Irvine, California, United States
• GSK Investigational Site — La Jolla, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Mission Viejo, California, United States
• GSK Investigational Site — Poway, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Spring Valley, California, United States
• GSK Investigational Site — Stockton, California, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.